rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Anavex Life Sciences Corp.

AVXL · Nasdaq

Health CareBiotechnologyNot moving yet

AVXL stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 53.7% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
2
Institutions holding
169 (-7)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

2 disclosed lines: House 2, Senate 0, executive 0; 1 people.

WhoDidAmountTraded
Chris Jacobs House: U.S. House ClerkNY27sold$1k–$15k12 Dec 2022filed 20 Jan 2023
Chris Jacobs House: U.S. House ClerkNY27bought$1k–$15k12 Oct 2022filed 16 Nov 2022

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders169-7 on the quarter
New · exited24 · 32
Reported value$97.1M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20268,055,628$20.9M+446,010+5.9%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20264,054,589$10.5M+190,639+4.9%
TWO SIGMA INVESTMENTS, LPreduced · filed 14 Aug 20263,046,538$7.9M-201,350−6.2%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20262,407,473$6.2M+219,198+10.0%
STATE STREET CORPreduced · filed 7 Aug 20261,922,770$5.0M-2,589,258−57.4%
FEDERATED HERMES, INC.added · filed 12 Aug 20261,071,809$2.8M+539,557+101.4%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026963,014$2.5M+206,222+27.2%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026948,633$2.5M+165,485+21.1%
Summit Financial, LLCreduced · filed 12 Aug 2026909,430$2.4M-31,025−3.3%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026890,634$2.3M+86,199+10.7%
31 Mar 2023 – 30 Jun 2026
114144174Mar 23Dec 23Dec 24Sep 25Jun 26

News

Everyone who traded it

Sandra Boenisch Company insiderPFO & Treasurer · last 24 Sep 20260 · 1
Christopher U. Missling Company insiderPresident and CEO · last 6 Jan 202639 · 3
Steffen Thomas Company insiderDirector · last 5 Jun 20251 · 0
Athanasios Skarpelos Company insiderDirector · last 31 Mar 20251 · 6
Claus Vander Velden Company insiderDirector · last 31 Mar 20250 · 0
Jiong Ma Company insiderDirector · last 31 Mar 20250 · 0
Peter D.o. Donhauser Company insiderDirector · last 31 Mar 20253 · 0
Chris Jacobs HouseNY27 · last 12 Dec 20221 · 1
Elliot Favus Company insiderDirector · last 21 May 20210 · 2
Bernd Metzner Company insiderDirector · last 22 Sep 20160 · 0
Harvey Lalach Company insiderPresident COO Secretary · last 29 May 20120 · 8
George F. Tidmarsh Company insiderExecutive Director · last 9 Feb 20120 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Interest coverFY 2025 · to 30 Sep 2025-10.99×
Share count trendFY 2025 · to 24 Nov 20253.1%
Cash and equivalentsFY 2025 · to 30 Sep 2025$102.6M

Analyst forecasts

No analyst forecasts yet.